Seattle pharma company eyes Boulder Valley for expansion
LOUISVILLE — Umoja Biopharma Inc., a Seattle-based developer of cancer therapies, could be expanding to the east as the company targets new manufacturing space in the Boulder Valley.
An application submitted to Louisville for a tax and fee rebate package suggests that Umoja is eyeing industrial sites in the Colorado Technology Center, as well as alternatives in Longmont, Broomfield and Westminster.
The company could take over about 150,000 square feet at 725 Tech Court in the CTC, according to a Louisville city memo.
A decision about a lease on that site is expected by August, with a goal of completing the first phase…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Early-bird registration ends at 11:59 p.m., Monday, Oct. 21, for the 17th annual Boulder Valley…
-
Hensel-Phelps Construction Co. is one of seven contractors nationwide to win a Trimble Construction Innovation…
-
The Idaho real estate company that purchased a 405-unit Fort Collins apartment building last month…
-
Delo Apartments, a 130-unit apartment building near downtown Louisville, sold this month for $42 million.
